IMPROVED BLADDER INJECTION SCHEME FOR ADMINISTRATION OF BOTULINUM TOXINS Russian patent published in 2021 - IPC A61K38/48 A61P13/10 

FIELD: medicine.

SUBSTANCE: group of inventions refers to treating bladder dysfunction. Disclosed are methods of introducing composition, containing a therapeutically effective amount of a clostridial neurotoxin derivative into at least one target region under the middle bladder line to reduce or prevent the risk of retention of urination, associated with the treatment of overactive bladder or detrusor neurogenic hyperactivity in the patient with clostridial neurotoxin derivatives or to reduce a patient's need for aseptic intermittent catheterisation (CIC), associated with treatment of overactive bladder or detrusor neurogenic hyperactivity with clostridial neurotoxin derivatives.

EFFECT: group of inventions provides reducing side effects when introducing a clostridial neurotoxin derivative into the urinary bladder.

13 cl, 6 dwg, 5 ex